Invagesic is a combination drug consisting of:[1]

It is indicated for management of fatigue, orthostatic hypotension and for the short-term treatment of apnea of prematurity in infants.[2]

References

  1. ↑ reference.md > Drug information for 'INVAGESIC' Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 4/7/2007
  2. ↑ Pharmacy Codes > Invagesic Retrieved April 2011
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.